Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Formulation And Development Of Topical Or Transdermal Film
Abstract: The present disclosure provides a topical or transdermal film comprising:a) a composition comprising at least one first active; and b) at least onefirstwater-soluble polymeric layer,wherein the polymeric layer forms a polymer matrix and the at least one first active is dispersed throughout the polymer matrix, and the at least one waterfirstsoluble polymeric layerand the at least one first active has a weight ratio in a range of 0.5:1 to 80,000:1. The topical or transdermal film can be used forburn healing, wound healing, skin lightening, and skin rejuvenation. The present disclosure, also describes a convenient process for preparation of the topical film.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
21 September 2017
Publication Number
31/2020
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
patent@sandhpartners.com
Parent Application
Applicants
BONAYU LIFESCIENCES PRIVATE LIMITED
D-503, Amoda Vallmark
Dodakamanhalli, Banerghatta Road,
Bangalore 560083, India.
Inventors
1. D AMIN, Purnima
Dept. of Pharmaceutical Sciences and Technology,
Institute of Chemical Technology (ICT),
Mumbai, India.
2. KATARIA, Vishal
Jubeln Lifesciences Pvt. Ltd. Bangalore Bioinnovation Centre, Inside IBAB Campus, Electronic City Phase 1,
Bangalore 560100, India.
3. BASU, Bhavna
Jubeln Lifesciences Pvt. Ltd. Bangalore Bioinnovation Centre, Inside IBAB Campus, Electronic City Phase 1,
Bangalore 560100, India.
4. MORAVKAR, Kailas Kalicharan
Jubeln Lifesciences Pvt. Ltd. Bangalore Bioinnovation Centre, Inside IBAB Campus, Electronic City Phase 1,
Bangalore 560100, India.
Specification
DESC:FORMULATION AND DEVELOPMENT OF TOPICAL OR TRANSDERMAL FILM ,CLAIMS:AS ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201741033521-STATEMENT OF UNDERTAKING (FORM 3) [21-09-2017(online)].pdf | 2017-09-21 |
| 2 | 201741033521-PROVISIONAL SPECIFICATION [21-09-2017(online)].pdf | 2017-09-21 |
| 3 | 201741033521-OTHERS [21-09-2017(online)].pdf | 2017-09-21 |
| 4 | 201741033521-FORM FOR SMALL ENTITY(FORM-28) [21-09-2017(online)].pdf | 2017-09-21 |
| 5 | 201741033521-FORM FOR SMALL ENTITY [21-09-2017(online)].pdf | 2017-09-21 |
| 6 | 201741033521-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [21-09-2017(online)].pdf | 2017-09-21 |
| 7 | 201741033521-EVIDENCE FOR REGISTRATION UNDER SSI [21-09-2017(online)].pdf | 2017-09-21 |
| 8 | 201741033521-DRAWINGS [21-09-2017(online)].pdf | 2017-09-21 |
| 9 | 201741033521-Proof of Right (MANDATORY) [20-12-2017(online)].pdf | 2017-12-20 |
| 10 | 201741033521-FORM-26 [20-12-2017(online)].pdf | 2017-12-20 |
| 11 | Correspondence by Agent_Proof of Right_POA_Form26_27-12-2017.pdf | 2017-12-27 |
| 12 | 201741033521-DRAWING [21-09-2018(online)].pdf | 2018-09-21 |
| 13 | 201741033521-CORRESPONDENCE-OTHERS [21-09-2018(online)].pdf | 2018-09-21 |
| 14 | 201741033521-COMPLETE SPECIFICATION [21-09-2018(online)].pdf | 2018-09-21 |
| 15 | 201741033521-Request Letter-Correspondence [03-10-2018(online)].pdf | 2018-10-03 |
| 16 | 201741033521-Form 1 (Submitted on date of filing) [03-10-2018(online)].pdf | 2018-10-03 |
| 17 | 201741033521-CERTIFIED COPIES TRANSMISSION TO IB [03-10-2018(online)].pdf | 2018-10-03 |
| 18 | 201741033521-Response to office action (Mandatory) [10-10-2018(online)].pdf | 2018-10-10 |
| 19 | 201741033521-RELEVANT DOCUMENTS [09-01-2019(online)].pdf | 2019-01-09 |
| 20 | 201741033521-FORM 13 [09-01-2019(online)].pdf | 2019-01-09 |
| 21 | 201741033521-FORM 3 [12-02-2019(online)].pdf | 2019-02-12 |
| 22 | 201741033521-STARTUP [11-03-2021(online)].pdf | 2021-03-11 |
| 23 | 201741033521-FORM28 [11-03-2021(online)].pdf | 2021-03-11 |
| 24 | 201741033521-FORM 18A [11-03-2021(online)].pdf | 2021-03-11 |
| 25 | 201741033521-FORM 3 [12-04-2021(online)].pdf | 2021-04-12 |
| 26 | 201741033521-Response to office action [17-09-2021(online)].pdf | 2021-09-17 |
| 27 | 201741033521-FER.pdf | 2021-10-17 |
| 28 | 201741033521-Information under section 8(2) [17-03-2022(online)].pdf | 2022-03-17 |
| 29 | 201741033521-FER_SER_REPLY [17-03-2022(online)].pdf | 2022-03-17 |
| 30 | 201741033521-US(14)-HearingNotice-(HearingDate-16-09-2022).pdf | 2022-08-31 |
| 31 | 201741033521-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [13-09-2022(online)].pdf | 2022-09-13 |
| 32 | 201741033521-RELEVANT DOCUMENTS [13-10-2022(online)].pdf | 2022-10-13 |
| 33 | 201741033521-POA [13-10-2022(online)].pdf | 2022-10-13 |
| 34 | 201741033521-FORM 13 [13-10-2022(online)].pdf | 2022-10-13 |
| 35 | 201741033521-US(14)-ExtendedHearingNotice-(HearingDate-08-03-2023).pdf | 2023-02-16 |
| 36 | 201741033521-US(14)-ExtendedHearingNotice-(HearingDate-09-03-2023).pdf | 2023-02-21 |
| 37 | 201741033521-FORM-26 [24-02-2023(online)].pdf | 2023-02-24 |
| 38 | 201741033521-Correspondence to notify the Controller [24-02-2023(online)].pdf | 2023-02-24 |
| 39 | 201741033521-Written submissions and relevant documents [23-03-2023(online)].pdf | 2023-03-23 |
Search Strategy
| 1 | SR33521E_16-03-2021.pdf |